Adam Wichniak

Summary

Affiliation: Institute of Psychiatry and Neurology
Country: Poland

Publications

  1. ncbi [The effects of antidepressants on sleep in depressed patients with particular reference to trazodone in comparison to agomelatine, amitriptyline, doxepin, mianserine and mirtazapine]
    Adam Wichniak
    Instytut Psychiatrii i Neurologii w Warszawie, III Klinika Psychiatryczna
    Pol Merkur Lekarski 31:65-70. 2011
  2. ncbi Sleep and antidepressant treatment
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
    Curr Pharm Des 18:5802-17. 2012
  3. ncbi [The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use]
    Adam Wichniak
    Department of Forensic Medicine, Institute of Psychiatry and Neurology, Warsaw, Poland
    Pol Merkur Lekarski 23:41-6. 2007
  4. ncbi Successful suppression of cataplectic attacks with tramadol
    Adam Wichniak
    Max Planck Institute of Psychiatry, Munich, Germany
    Neurology 61:864-5. 2003
  5. ncbi Patients with insomnia and subthreshold depression show marked worsening of insomnia after discontinuation of sleep promoting medication
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego 9, 02 957 Warsaw, Poland
    Prog Neuropsychopharmacol Biol Psychiatry 35:1671-6. 2011
  6. ncbi Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
    J Psychopharmacol 20:80-5. 2006
  7. doi Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego, Warsaw, Poland
    J Psychiatr Res 45:1381-6. 2011
  8. ncbi [The use of event related potentials in psychiatric research]
    Adam Wichniak
    III Klinika Psychiatryczna, Instytut Psychiatrii i Neurologii, Warszawa
    Przegl Lek 67:732-5. 2010
  9. ncbi Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine
    Dagmar A Schmid
    Max Planck Institute of Psychiatry, Munich, Germany
    Neuropsychopharmacology 31:832-44. 2006
  10. ncbi Sleep as a biomarker for depression
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
    Int Rev Psychiatry 25:632-45. 2013

Detail Information

Publications19

  1. ncbi [The effects of antidepressants on sleep in depressed patients with particular reference to trazodone in comparison to agomelatine, amitriptyline, doxepin, mianserine and mirtazapine]
    Adam Wichniak
    Instytut Psychiatrii i Neurologii w Warszawie, III Klinika Psychiatryczna
    Pol Merkur Lekarski 31:65-70. 2011
    ..Too late administration time and too high dose are the most common factors related to failure of insomnia treatment with these drugs...
  2. ncbi Sleep and antidepressant treatment
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
    Curr Pharm Des 18:5802-17. 2012
    ..One exception is doxepin, which has been approved for the treatment of insomnia characterized by difficulties in maintaining sleep...
  3. ncbi [The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use]
    Adam Wichniak
    Department of Forensic Medicine, Institute of Psychiatry and Neurology, Warsaw, Poland
    Pol Merkur Lekarski 23:41-6. 2007
    ..Antidepressants are important alternative for long-term insomnia treatment. The aim of the study was compared the efficacy of trazodone in the treatment of patients with primary insomnia with and without prior history of hypnotics use...
  4. ncbi Successful suppression of cataplectic attacks with tramadol
    Adam Wichniak
    Max Planck Institute of Psychiatry, Munich, Germany
    Neurology 61:864-5. 2003
  5. ncbi Patients with insomnia and subthreshold depression show marked worsening of insomnia after discontinuation of sleep promoting medication
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego 9, 02 957 Warsaw, Poland
    Prog Neuropsychopharmacol Biol Psychiatry 35:1671-6. 2011
    ..To investigate whether the outcome of treatment with trazodone CR in primary insomnia differs between patients with and without subthreshold depression...
  6. ncbi Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
    J Psychopharmacol 20:80-5. 2006
    ..However, as no spike- or sharp-slow-wave complexes were observed, the risk of epileptic seizure during olanzapine treatment can be regarded as low, as long as olanzapine is not combined with some other antipsychotic...
  7. doi Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Sobieskiego, Warsaw, Poland
    J Psychiatr Res 45:1381-6. 2011
    ..These changes are linked to negative and depressive symptoms...
  8. ncbi [The use of event related potentials in psychiatric research]
    Adam Wichniak
    III Klinika Psychiatryczna, Instytut Psychiatrii i Neurologii, Warszawa
    Przegl Lek 67:732-5. 2010
    ....
  9. ncbi Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine
    Dagmar A Schmid
    Max Planck Institute of Psychiatry, Munich, Germany
    Neuropsychopharmacology 31:832-44. 2006
    ..A weight gain of approximately 3 kg was observed. This unique profile of changes is compatible with the action of mirtazapine at 5-HT-2 receptors, at presynaptic adrenergic alpha 2 receptors, at the HPA system, and on ghrelin and leptin...
  10. ncbi Sleep as a biomarker for depression
    Adam Wichniak
    Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
    Int Rev Psychiatry 25:632-45. 2013
    ....
  11. doi Heritability of sleep electroencephalogram
    Urte Ambrosius
    Max Planck Institute of Psychiatry, Munich, Germany
    Biol Psychiatry 64:344-8. 2008
    ..Here we report on the results of a classical twin study in monozygotic (MZ) and dizygotic (DZ) twin pairs examining the genetic effect on sleep electroencephalogram (EEG) composition...
  12. ncbi [Neurophysiological examinations in narcolepsy]
    Aleksandra Wierzbicka
    Ośrodek Medycyny Snu, Zakład Neurofizjologii Klinicznej, Instytut Psychiatrii i Neurologii, Warszawa
    Przegl Lek 67:726-8. 2010
    ..Establishing the proper diagnosis is very important, because of the negative impact of narcolepsy on patients' functioning in social-life and the possibility of improvement of quality of life with adequate treatment...
  13. ncbi Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression
    Adam Wichniak
    Max Planck Institute of Psychiatry, Kraepelinstr 10, 80804 Munich, Germany
    Psychoneuroendocrinology 29:1101-8. 2004
    ..In view of the GABAergic inhibition of HPA system activity and the anxiogenic effect of CRH, benzodiazepine withdrawal symptoms may be partly due to a disinhibition of the HPA system during discontinuation of benzodiazepines...
  14. ncbi Alterations in pattern of rapid eye movement activity during REM sleep in depression
    Adam Wichniak
    Sleep Disorders Center, Department of Clinical Neurophysiology, Institute of Psychiatry and Neurology, 9 Sobieski St, 02 957 Warsaw, Poland
    Acta Neurobiol Exp (Wars) 62:243-50. 2002
    ..All applied methods for scoring of REM density distinguished depressed patients from healthy controls with comparable accuracy...
  15. ncbi REM sleep behaviour disorder in narcolepsy
    Aleksandra Wierzbicka
    Zakład Neurofizjologii Klinicznej, Ośrodek Medycyny Snu, Instytut Psychiatrii i Neurologii w Warszawie
    Neurol Neurochir Pol 43:421-7. 2009
    ..The aim of the study was to evaluate the incidence of REM sleep behaviour disorder (RBD) in consecutive patients with narcolepsy referred to our sleep disorders centre...
  16. ncbi [Pharmacological treatment of insomnia]
    Adam Wichniak
    III Klinika Psychiatryczna IPiN w Warszawie
    Psychiatr Pol 40:563-77. 2006
    ..This article reviews the sleep promoting drugs and substances that can be used for treatment of chronic insomnia...
  17. ncbi [Restless legs syndrome and periodic limb movements in sleep: clinical features, epidemiology, diagnosis]
    Adam Wichniak
    Poradni Zaburzeń Snu Instytutu Psychiatrii i Neurologii w Warszawie
    Neurol Neurochir Pol 36:1173-84. 2002
    ..The clinical diagnosis of the RLS is based on the criteria of The International Restless Legs Syndrome Study Group, and the most useful laboratory support is gained from all-night polysomnography and high-resolution actography...
  18. ncbi The influence of polysomnography on the Multiple Sleep Latency Test and other measures of daytime sleepiness
    Adam Wichniak
    Sleep Disorders Centre, Department of Psychiatry, University of Regensburg, Universitätsstr 84, 93053, Regensburg, Germany
    Physiol Behav 75:183-8. 2002
    ..The aim of this study was to examine whether PSG performed in a sleep laboratory has any influence on the MSLT and other measures of daytime sleepiness...
  19. ncbi The influence of age and sex on sleep latency in the MSLT-30--a normative study
    Peter Geisler
    Sleep Disorders and Research Centre, Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany
    Sleep 29:687-92. 2006
    ..The aim of the study was to provide normative data for the clinical use of the MSLT-30 and to evaluate the influence of age, sex, and other sociodemographic variables...